Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Aterian Inc (ATER) Price & Performance

Amphastar Pharmaceuticals IncTrade
Aterian IncTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Aterian Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 163.3× Aterian Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.

AMPHATER
Market Cap
$868.62M$5.32M
Sector
HealthConsumer Cyclical
52-Week High
$30.81$1.39
52-Week Low
$16.87$0.36
Enterprise Value
$1.27B$5.90M

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER